Ajinomoto Althea, Inc. is expanding capacity with the addition of a second manufacturing shift to support sterile fill and finish parenteral manufacturing operations for clinical and commercial drug programs. The second shift will come on-line in early June, increasing the number of manufacturing slots for drug programs, reducing lead times from project kickoff to fill date. To support this increase in parenteral manufacturing capacity, Althea has invested in additional operational capabiliti...